Literature DB >> 32810303

Scabies outbreak during home confinement due to the SARS-CoV-2 pandemic.

I Martínez-Pallás1, B Aldea-Manrique1, M Ramírez-Lluch1, J Manuel Vinuesa-Hernando2, M Ara-Martín1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32810303      PMCID: PMC7461221          DOI: 10.1111/jdv.16879

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   9.228


× No keyword cloud information.
Editor In response to the rapid spread of COVID‐19 at the start of the pandemic, governments introduced severe measures of home confinement and isolation of the population in an effort to prevent their health systems from collapsing. On March 14, with more than 4000 confirmed cases, Spain began its nationwide lockdown which has extended for almost three months. In recent weeks, numerous articles have reported a wide range of skin symptoms of COVID‐19, but there are other dermatological conditions that may have been aggravated during this global pandemic. Scabies is a highly contagious skin infestation caused by the mite Sarcoptes scabiei (variety hominis). In developed countries, scabies is usually observed sporadically or as institutional outbreaks in hospitals, nursing homes, prisons, long‐term care facilities or in displaced persons and asylum seekers. , However, we have observed a significant increase of scabies cases in our region during the confinement period (March, April and May 2020) compared to the average for the same period during the previous five years (64 vs. 18.6 patients). In an attempt to analyse how the confinement had influenced the scabies infestation, we have compared the characteristics of the patients diagnosed by dermatologists (based on clinical and dermatoscopic criteria) in that quarter during the last five years with those diagnosed during the confinement (Table 1). The lockdown changed not only the number of patients infested, but also the features of the disease and our management (Fig. 1).
Table 1

Comparison of demographic, clinical and therapeutic data between scabies cases diagnosed during the months of confinement and non‐confinement

Confinement No confinement Statistical comparison
N6493
Gender
Male3248χ2 (1) = 0.01, > 0.05
Female3245
Age (mean + SD)30.87 ± 21.2832.16 ± 25.11 t (155) = −0.336, > 0.05
Cohabitants +52 (81.25%)61 (65.59%)χ2 (1) = 3.865, P < 0.05
Family Cluster35 (54.68%)18 (19.35%)χ2 (1) = 19.61, P < 0.05
Symptoms duration9.75 ± 5.855.77 ± 5.172(t (154) = 4.47, P < 0.05)
Previous treatment48 (75%)14 (15.05%)χ2 (1) = 54.53, P < 0.05
Treatment with permethrin64 (100%)93 (100%)
Previous applications of permethrin (mean + SD)4.10 ± 2.941.64 ± 0.84 t(59.9) = −5.123, P < 0.05
Treatment with ivermectin36 (60.93%)4 (4.3%)χ2 (1) = 58.33, P < 0.05

Period between March and May 2020.

Period between March and May from 2015 to 2019.

Figure 1

Home confinement effect on scabies infestation.

Comparison of demographic, clinical and therapeutic data between scabies cases diagnosed during the months of confinement and non‐confinement Period between March and May 2020. Period between March and May from 2015 to 2019. Home confinement effect on scabies infestation. First, spending more time at home and therefore with relatives, increases the risk of transmitting the parasite through direct contact or by fomites, a rise that has also been observed during the winter season. Second, we observed that during the period of confinement, the duration of symptoms reported by patients was significantly longer. This seems to be explained by the population's fear of leaving home unless it was strictly necessary, not seeking medical attention until they got desperate by the pruritus. The detection and treatment of the index case is the most effective measure to stop scabies spread, and this delay in diagnosis may have led to an increased intrafamilial transmission in our sample, as it is described in other studies. , The proportion of patients with history of family members or cohabitants diagnosed with scabies (or suspected) was significantly higher in the confinement group, reaching more than the 80%; and more than the half of our sample consulted the dermatologist with their cohabitants, conforming ‘family clusters’, while only a 20% did in the non‐confinement group. Regarding to treatment, all members of our sample were treated with topical 5% permethrin cream, as it is the first‐line treatment in our country ; however, there is a higher proportion of patients who had already been treated by their primary healthcare providers during confinement because general practitioners made an effort to avoid hospital referral of non‐urgent conditions due to the public health situation. In addition, the number of permethrin applications in confined patients was significantly superior, and therefore, this group ended requiring oral treatment with ivermectin more frequently. Permethrin failure has often been observed in major outbreaks in institutions, due to complications in carrying out decontamination measures or in completing topical treatment, with frequent reinfections among cohabitants. On these occasions, oral treatment with ivermectin is considered as the first choice for controlling infestation. , , In our opinion, during home confinement, minor outbreaks have arised within each family group, and management difficulties are similar to those previously mentioned for institutional outbreaks, so perhaps the approach should be similar. The results presented are from a single hospital in Spain, and these results cannot be generalized; however, due to the dramatic evolution of the pandemic, we could suffer again a confinement and this work provides a basis for future researchers to implement and evaluate preventive actions to reduce and recognize early cases of scabies in this context.

Conflict of interest

None declared.

Funding sources

There has been no financial support for this work that could have influenced its outcome.
  8 in total

Review 1.  Scabies: New Opportunities for Management and Population Control.

Authors:  Li Jun Thean; Daniel Engelman; John Kaldor; Andrew C Steer
Journal:  Pediatr Infect Dis J       Date:  2019-02       Impact factor: 2.129

2.  Investigation of a scabies outbreak in a kindergarten in Constance, Germany.

Authors:  L Ariza; B Walter; C Worth; S Brockmann; M-L Weber; H Feldmeier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09-28       Impact factor: 3.267

Review 3.  S1 guidelines on the diagnosis and treatment of scabies - short version.

Authors:  Cord Sunderkötter; Hermann Feldmeier; Regina Fölster-Holst; Bertram Geisel; Sabine Klinke-Rehbein; Alexander Nast; Sandra Philipp; Bernhardt Sachs; Julia Stingl; Johanna Stoevesandt; Henning Hamm
Journal:  J Dtsch Dermatol Ges       Date:  2016-11       Impact factor: 5.584

4.  Ivermectin for the control of scabies outbreaks in the UK.

Authors:  Jo Middleton; Stephen L Walker; Thomas House; Michael G Head; Jackie A Cassel
Journal:  Lancet       Date:  2019-12-07       Impact factor: 79.321

5.  An outbreak of scabies in a long-term care facility: the role of misdiagnosis and the costs associated with control.

Authors:  Gretha de Beer; Mark A Miller; Lucie Tremblay; Johanne Monette
Journal:  Infect Control Hosp Epidemiol       Date:  2006-04-20       Impact factor: 3.254

6.  Implementation and evaluation of an algorithm for the management of scabies outbreaks.

Authors:  Simon M Mueller; Stefan Gysin; Michael Schweitzer; Simon Schwegler; Peter Haeusermann; Peter Itin; Thomas Bart; Ruth Spieler Denz; Thomas Steffen; Richard Kuehl; Andreas F Widmer; Oliver Brandt
Journal:  BMC Infect Dis       Date:  2019-02-28       Impact factor: 3.090

Review 7.  Scabies: Advances in Noninvasive Diagnosis.

Authors:  Giuseppe Micali; Francesco Lacarrubba; Anna Elisa Verzì; Olivier Chosidow; Robert A Schwartz
Journal:  PLoS Negl Trop Dis       Date:  2016-06-16

Review 8.  Cutaneous signs in COVID-19 patients: A review.

Authors:  Uwe Wollina; Ayşe Serap Karadağ; Christopher Rowland-Payne; Anca Chiriac; Torello Lotti
Journal:  Dermatol Ther       Date:  2020-05-29       Impact factor: 2.851

  8 in total
  7 in total

1.  The effect of the COVID-19 pandemic on dermatology consultation requests from adult and paediatric emergency departments.

Authors:  Neslihan Demirel Öğüt; Gülsün Hazan Tabak; Duygu Gülseren; Başak Yalıcı-Armağan; Neslihan Akdoğan; Sibel Doğan; Gonca Elçin; Ayşen Karaduman; Sibel Ersoy Evans
Journal:  Int J Clin Pract       Date:  2021-09-27       Impact factor: 3.149

2.  Ancient Disease Making a Comeback Due to Covid-19 Pandemic.

Authors:  Sanjeev Gupta; Ajinkya Vinayak Gujrathi; Shobhita Gupta; Anuradha Yadav
Journal:  Indian J Dermatol       Date:  2022 Jan-Feb       Impact factor: 1.757

3.  Public interest in dermatologic symptoms, conditions, treatments, and procedures during the COVID-19 pandemic: Insights from Google Trends.

Authors:  Kübra Esen-Salman; Özlem Akın-Çakıcı; Sinan Kardeş; Andaç Salman
Journal:  Dermatol Ther       Date:  2021-02-25       Impact factor: 3.858

4.  Ivermectin as a multifaceted drug in COVID-19: Current insights.

Authors:  Ankur Khandelwal; Gyaninder Pal Singh; Shaista Jamil
Journal:  Med J Armed Forces India       Date:  2021-07-26

5.  Scabies outbreak during COVID-19: an Italian experience.

Authors:  Mario De Lucia; Luca Potestio; Luca Costanzo; Gabriella Fabbrocini; Lucia Gallo
Journal:  Int J Dermatol       Date:  2021-08-05       Impact factor: 3.204

6.  Scabies in Spain? A comprehensive epidemiological picture.

Authors:  Lidia Redondo-Bravo; Beatriz Fernandez-Martinez; Diana Gómez-Barroso; Alin Gherasim; Montserrat García-Gómez; Agustín Benito; Zaida Herrador
Journal:  PLoS One       Date:  2021-11-01       Impact factor: 3.240

7.  Prevalence of Scabies in the Covid-19 Pandemic Period and Determination of Risk Factors for Scabies: a Hospital-Based Cross-Sectional Study in Northeast Turkey.

Authors:  Z Karaca Ural; B Çatak; E Ağaoğlu
Journal:  Acta Parasitol       Date:  2022-02-02       Impact factor: 1.534

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.